LATEST NEWS

EVENTS

NEWS

Uncategorized
Mike

Covid Vaccine Updates

COVID vaccine update June 21: In view of the recent increase in COVID infections in the UK we would like to issue a word of caution to red cell teams

Read More »

TOR – Sickle Cell Care

All-Party Parliamentary Group on Sickle Cell and Thalassaemia: Terms of reference for inquiry into sickle cell care Inquiry into Sickle Call Care (ToR)

Read More »
News
Mike

Clinical Trials & Research

CSL Behring‘s HEMOPEXIN FIRST IN HUMAN STUDY IN STABLE SICKLE DISEASE Study Title: A Phase 1, Multi-Center, Open Label, Single Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics

Read More »

Noticeboard

Scroll to Top